278 related articles for article (PubMed ID: 20532823)
1. Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.
Spiekerkoetter U; Wood PA
J Inherit Metab Dis; 2010 Oct; 33(5):539-46. PubMed ID: 20532823
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.
Spiekerkoetter U
J Inherit Metab Dis; 2010 Oct; 33(5):527-32. PubMed ID: 20449660
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
[TBL] [Abstract][Full Text] [Related]
4. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation.
Houten SM; Wanders RJ
J Inherit Metab Dis; 2010 Oct; 33(5):469-77. PubMed ID: 20195903
[TBL] [Abstract][Full Text] [Related]
5. Disease mechanisms and protein structures in fatty acid oxidation defects.
Gregersen N; Olsen RK
J Inherit Metab Dis; 2010 Oct; 33(5):547-53. PubMed ID: 20151199
[TBL] [Abstract][Full Text] [Related]
6. Long-chain fatty acid oxidation during early human development.
Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of fatty acid oxidation disorders.
Bennett MJ
J Inherit Metab Dis; 2010 Oct; 33(5):533-7. PubMed ID: 20824345
[TBL] [Abstract][Full Text] [Related]
8. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models.
Diekman EF; van Weeghel M; Wanders RJ; Visser G; Houten SM
FASEB J; 2014 Jul; 28(7):2891-900. PubMed ID: 24648546
[TBL] [Abstract][Full Text] [Related]
9. Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting.
Lindner M; Hoffmann GF; Matern D
J Inherit Metab Dis; 2010 Oct; 33(5):521-6. PubMed ID: 20373143
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid oxidation disorders: outcome and long-term prognosis.
Wilcken B
J Inherit Metab Dis; 2010 Oct; 33(5):501-6. PubMed ID: 20049534
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.
Wajner M; Amaral AU
Biosci Rep; 2015 Nov; 36(1):e00281. PubMed ID: 26589966
[TBL] [Abstract][Full Text] [Related]
12. Current issues regarding treatment of mitochondrial fatty acid oxidation disorders.
Spiekerkoetter U; Bastin J; Gillingham M; Morris A; Wijburg F; Wilcken B
J Inherit Metab Dis; 2010 Oct; 33(5):555-61. PubMed ID: 20830526
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.
Lund AM; Skovby F; Vestergaard H; Christensen M; Christensen E
J Inherit Metab Dis; 2010 Oct; 33(5):495-500. PubMed ID: 20066495
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
[TBL] [Abstract][Full Text] [Related]
15. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
[TBL] [Abstract][Full Text] [Related]
16. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.
Yamada K; Taketani T
J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918
[TBL] [Abstract][Full Text] [Related]
17. Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?
Olsen RK; Cornelius N; Gregersen N
Mol Genet Metab; 2013; 110 Suppl():S31-9. PubMed ID: 24206932
[TBL] [Abstract][Full Text] [Related]
18. Update on mitochondrial fatty acid oxidation disorders.
Spiekerkoetter U; Mayatepek E
J Inherit Metab Dis; 2010 Oct; 33(5):467-8. PubMed ID: 20842433
[No Abstract] [Full Text] [Related]
19. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
Stanley CA
Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
[TBL] [Abstract][Full Text] [Related]
20. Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidation.
Schuler AM; Gower BA; Matern D; Rinaldo P; Vockley J; Wood PA
Mol Genet Metab; 2005 May; 85(1):7-11. PubMed ID: 15862275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
